Recent Publications

2023

Racial Differences in the Presentation and Progression of Huntington's Disease.

Buchanan DA, Brown AE, Osigwe EC, Pfalzer AC, Mann LG, Yan Y, Kang H, Claassen DO.Mov Disord. 2023 Aug 10. doi: 10.1002/mds.29536.

Cerebrospinal Fluid Flow in Patients with Huntington's Disease.

Hett K, Eisma JJ, Hernandez AB, McKnight CD, Song A, Elenberger J, Considine C, Donahue MJ, Claassen DO.Ann Neurol. 2023 Jul 26. doi: 10.1002/ana.26749.

Cerebellar impulsivity-compulsivity assessment scale.

Lin CR, Amokrane N, Chen S, Chen TX, Lai RY, Trinh P, Minyetty MJ, Emmerich H, Pan MK, Claassen DO, Kuo SH.Ann Clin Transl Neurol. 2023 Jan;10(1):48-57. doi: 10.1002/acn3.51698.

2022
Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.

Claassen DO, Ayyagari R, Goldschmidt D, Zhou M, Leo S, Ribalov R.Adv Ther. 2022 Apr;39(4):1784-1793. doi: 10.1007/s12325-022-02046-z.

Dysarthria Subgroups in Talkers with Huntington's Disease: Comparison of Two Data-Driven Classification Approaches.

Kim D, Diehl S, de Riesthal M, Tjaden K, Wilson SM, Claassen DO, Mefferd AS.Brain Sci. 2022 Apr 13;12(4):492. doi: 10.3390/brainsci12040492. 

Impulsivity Trait Profiles in Patients With Cerebellar Ataxia and Parkinson Disease.

Chen TX, Lin CR, Aumann MA, Yan Y, Amokrane N, Desai NA, Kang H, Claassen DO, Kuo SH.Neurology. 2022 Jul 12;99(2):e176-e186. doi: 10.1212/WNL.

2021

Measuring Functional Status in Huntington's Disease.

Gibson JS, Ridner SH, Dietrich MS, Sohn MB, Rhoten BA, Claassen DO.Mov Disord. 2021 Mar;36(3):757-761. doi: 10.1002/mds.28363. 
Symptoms of Medication Withdrawal in Parkinson's Disease: Considerations for Informed Consent in Patient-Oriented Research.

Hay KR, Kukreti N, Trujillo P, Lin YC, Kang H, Claassen DO.Pharmaceut Med. 2021 May;35(3):163-167. doi: 10.1007/s40290-021-00387-8.

Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington's Disease.

Claassen DO, DeCourcy J, Mellor J, Johnston C, Iyer RG.J Health Econ Outcomes Res. 2021 Jun 21;8(1):99-105. doi: 10.36469/001c.24620.

2020

The Regulation of Cerebral Spinal Fluid Flow and its Relevance to the Glymphatic System.

McKnight CD, Rouleau RM, Donahue MJ, Claassen DO.

Current Neurology and Neuroscience Reports . 2020 October. DOI: 10.1007/s11910-020-01077-9

Understanding speech and swallowing difficulties in individuals with Huntingtons disease: Validation of the HDQLIFE Speech Difficulties and Swallowing Difficulties Item Banks.

Carlozzi NE, Boileau NR, Roberts A, Dayalu P, Hanifan DL, Miner JA, Claassen D, Provost EM.

Quality of Life Research. 2020 August. DOI: 10.1007/s11136-020-02608-0

Investigating the Interplay of Working Memory, Affective Symptoms, and Coping with Stress in Offspring of Parents with Huntington's Disease

Ciriegio AE, Pfalswer AC, Hale L, McDonell KE, Claassen DO, Compas BE.

Neuropsychology. In Press.

Structural Correlates of the Sensorimotor Cerebellum in Parkinson's Disease and Essential Tremor.

Lopez AM, Trufillo P, Hernandez AB, Lin YC, Kang H, Bradley E, Zald DH, Claassen DO.

Movement Disorders. 2020 Jul. DOI: 10.1002/mds.28044

Self-reported rates of impulsivity in Parkinson's Disease.

Aumann MA, Stark AJ, Hughes SB, Lin YC, Kang H, Bradley E, Zald DH, Claassen DO.

Annals of Clinical and Translational Neurology. 2020 Feb. DOI: 10.1002/acn3.51016

2019

Quantitative magnetization transfer imaging of the human locus coeruleus.

Trujillo P, Petersen KJ, Cronin MJ, Lin YC, Kang G, Donahue MJ, Smith SA, Claassen DO.

Neuroimage. 2019 Oct; 200: 191-198. DOI: 10.1016/j.neuroimage.2019.06.049. 

Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.

Claassen DO, Philibin M, Carroll B.

Expert Opinion on Pharmacotherapy. 2019 Oct; 18: 2209-21. DOI: 10.1080/14656566.2019.1674281

A systematic review of neuropsychiatric symptoms and functional capacity in Huntington's Disease.

Sellers J, Ridner SH, Claassen DO.

The Journal of Neuropsychiatry and Clinical Neurosciences. 2019 Aug. DOI: 10.1176/appi.neuropsych.18120319

Action Control Deficits in Patients with Essential Tremor.

Hughes S, Claassen DO, Van Den Wildenberg WPM, Phibbs FT, Bradley EB, Wylie SA, van Wouwe NC.

Journal of International Neuropsychological Society. 2019 Feb; 24(2):156-64 DOI: 10.1017/S1355617718001054

2018

Structural and functional connectivity of the nondecussating dentato-rubro-thalamic tract.

Petersen KJ, Reid JA, Chakravorti S, Juttukonda MR, Franco G, Trujillo P, Stark AJ, Dawant BM, Donahue MJ, Claassen DO.

Neuroimage. 2018 Aug 1;176:364-371. doi: 10.1016/j.neuroimage.2018.04.074. Epub 2018 May 4.

[18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease.

Stark AJ, Smith CT, Petersen KJ, Trujillo P, van Wouwe NC, Donahue MJ, Kessler RM, Deutch AY, Zald DH, Claassen DO.

Neuroimage Clin. 2018 Feb 10;18:433-442. doi: 10.1016/j.nicl.2018.02.010. eCollection 2018.

Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors.

Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, Kang H, Donahue MJ, Kessler RM, Zald DH, Claassen DO.

J Neurosci. 2018 Mar 28;38(13):3230-3239. doi: 10.1523/JNEUROSCI.3082-17.2018. Epub 2018 Feb 26.

2017

Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.

Petersen K, Van Wouwe N, Stark A, Lin YC, Kang H, Trujillo-Diaz P, Kessler R, Zald D, Donahue MJ, Claassen DO.

Hum Brain Mapp. 2018 Jan;39(1):509-521. doi: 10.1002/hbm.23860. Epub 2017 Oct 31.

Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors.

Claassen DO, Stark AJ, Spears CA, Petersen KJ, van Wouwe NC, Kessler RM, Zald DH, Donahue MJ.

Mov Disord. 2017 Jun 19. doi: 10.1002/mds.27047. [Epub ahead of print]

Dopamine Selectively Modulates the Outcome of Learning Unnatural Action-Outcome Associations.

Van Wouwe NC, Claassen DO, Neimat JS, Kanoff KE, Wylie SA.

J Cogn Neurosci. 2017 Jan 27:1-11. doi: 10.1162/jocn_a_01099. [Epub ahead of print]

2016

Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere.

Claassen DO, McDonell KE, Donahue M, Rawal S, Wylie SA, Neimat JS, Kang H, Hedera P, Zald D, Landman B, Dawant B, Rane S.

Brain Behav. 2016 Oct 6;6(12):e00573. doi: 10.1002/brb3.573.

Dopamine and temporal attention: An attentional blink study in Parkinson's disease patients on and off medication.

Slagter HA, van Wouwe NC, Kanoff K, Grasman RP, Claassen DO, van den Wildenberg WP, Wylie SA.

Neuropsychologia. 2016 Oct;91:407-414. doi: 10.1016/j.neuropsychologia.2016.09.006.

Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.

Claassen DO, Dobolyi DG, Isaacs DA, Roman OC, Herb J, Wylie SA, Neimat JS, Donahue MJ, Hedera P, Zald DH, Landman BA, Bowman AB, Dawant BM, Rane S.

Aging Dis. 2016 May 27;7(3):220-9. doi: 10.14336/AD.2015.1110.

Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction.

Herb JN, Rane S, Isaacs DA, Van Wouwe N, Roman OC, Landman BA, Dawant BM, Hedera P, Zald DH, Neimat JS, Wylie SA, Donahue MJ, Claassen DO.

J Parkinsons Dis. 2016 May 5;6(2):441-51. doi: 10.3233/JPD-150753.

Dissociable Effects of Dopamine on the Initial Capture and the Reactive Inhibition of Impulsive Actions in Parkinson's Disease.

van Wouwe NC, Kanoff KE, Claassen DO, Spears CA, Neimat J, van den Wildenberg WP, Wylie SA.

J Cogn Neurosci. 2016 May;28(5):710-23. doi: 10.1162/jocn_a_00930.

2015

Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors.

Claassen DO, van den Wildenberg WP, Harrison MB, van Wouwe NC, Kanoff K, Neimat JS, Wylie SA.

Pharmacol Biochem Behav. 2015 Feb;129:19-25. doi: 10.1016/j.pbb.2014.11.017.

2014

Speed pressure in conflict situations impedes inhibitory action control in Parkinson's disease.

van Wouwe NC, van den Wildenberg WP, Claassen DO, Kanoff K, Bashore TR, Wylie SA.

Biol Psychol. 2014 Sep;101:44-60. doi: 10.1016/j.biopsycho.2014.07.002.